CION Ameerpet
Radiation Therapy · Theranostics & Radioisotope Therapy
Lu-177 and Radioisotope Therapy — The Side Effects, Listed Honestly
Medically reviewed by Dr. Venkata Sushma P, Radiation Oncologist (MBBS · MD, Radiation Oncology) · Last reviewed August 2026
Radioisotope therapy travels in your bloodstream, so its side effects are not the ones people describe after daily radiation on a machine. This page sets out what is actually common after Lu-177 and related radioisotope treatments, why the kidneys and bone marrow matter more than anything else, and exactly what your team checks between cycles.
- The real toxicity profile — tiredness, dry mouth, nausea, blood counts and a bone-pain flare — not a generic radiation side-effect list borrowed from another treatment.
- Kidneys and marrow, explained — why these two organs decide whether your next cycle goes ahead, and what a postponed cycle actually means.
- The monitoring schedule — which blood tests are done before every cycle, when counts hit their lowest point, and what continues after the course ends.
- Coordinated, not outsourced — delivered at an NABH-accredited partner nuclear medicine centre, with your CION team managing the plan and the follow-up.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
What are the common side effects of Lu-177 and radioisotope therapy?
The most commonly reported are tiredness, mild nausea and a dry mouth, along with a fall in blood counts and a temporary flare of bone pain. Kidney blood tests can drift over a course. Most effects are mild to moderate, build slowly across cycles, and are managed rather than simply endured.
Almost every side-effect list you will find online was written for external beam radiation — the daily treatment on a machine, with skin marks and a mask. That list is the wrong one here, and reading it sets you up to worry about the wrong things.
Radioisotope therapy works differently. The radiation is carried in the bloodstream and sticks where the disease is, so there is no skin reaction, no daily hospital trip and nothing aimed at one part of your body. What there is instead: organs that carry the same target, or that handle the isotope on its way out, take a share of the dose. That single fact explains the entire list on this page. If you want the mechanism side by side, our comparison of radioisotope therapy and external beam radiation sets out when each is used.
Radioisotope therapy is delivered at an NABH-accredited partner nuclear medicine centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate a nuclear medicine facility, a linear accelerator or any other radiotherapy equipment.
Did you know?
A dry mouth after Lu-177 therapy for prostate cancer is not a coincidence and not dehydration. Salivary glands carry a small amount of the same surface protein the treatment is built to find, so they pick up a share of the dose. It is one of the clearest examples of why a targeted treatment still has side effects — and why they are predictable enough to plan for.
Question one
What is common, when does it appear, and what helps?
Read this as a map of what to expect, not a warning list. Most of these are mild, most settle between cycles, and every one of them has something your team can do about it.
Tiredness is the most common. A dry mouth, mild nausea and reduced appetite follow. Blood counts fall in many patients, usually a few weeks after a cycle rather than immediately. Kidney blood tests can drift slowly. A short bone-pain flare is common when bone deposits are being treated.
| What you may notice | Why it happens | When it usually shows | What usually helps |
|---|---|---|---|
| Tiredness | A general response to radiation delivered through the bloodstream | Builds through the week after a cycle, and gradually across the course | Short walks rather than bed rest, protected sleep, and planning commitments around the first week of each cycle |
| Dry mouth, taste changes | Salivary glands carry a share of the dose in several radioisotope treatments | Days after a cycle; can persist between cycles | Sip fluids through the day, sugar-free lozenges or chewing gum, and ask your team about a prescribed rinse if it becomes troublesome |
| Nausea, reduced appetite | A common early effect in the days after an infusion | First two to five days after a cycle | Small frequent meals, and an anti-sickness medicine if your team prescribes one |
| Falling blood counts | Bone marrow sits next to bone, so marrow near treated bone deposits receives radiation | Lowest point is usually a few weeks after a cycle, not immediately | Blood tests before every cycle; a cycle is delayed if counts have not recovered, and fever, bleeding or unusual bruising is reported the same day |
| Changes in kidney blood tests | The dose that is not taken up leaves through the kidneys, so they receive a share on the way out | Usually a slow drift across a full course, felt by very few patients | Good fluid intake around each cycle and routine kidney blood tests through the course |
| A short flare of bone pain | Treated bone deposits can become briefly more painful as they respond | First few days after a cycle, then settles | Tell your team before the cycle if you already have bone pain, so pain control is planned rather than improvised |
This reflects what is commonly described in NCCN and ASTRO patient guidance for radioisotope treatments. It is not exhaustive, and the exact list depends on which isotope you are having and at what dose — your written consent discussion at the partner centre is where the full list for your treatment is covered.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a second opinion before the next cycle
A course of radioisotope therapy runs over months. One review of your scans, blood reports and side effects is free, confidential and carries no obligation to change anything.
Question two
What affects the kidneys and the bone marrow?
Two organs decide how a course goes. The kidneys clear the part of the dose the cancer does not take up, so they receive radiation on the way out. Bone marrow sits next to bone, so marrow near treated bone deposits is irradiated too. Both are measured, not guessed.
These are the two limits your team works within. They are also the two reasons a cycle gets postponed. Understanding them turns a delay from a frightening surprise into an expected part of the schedule.
The kidneys
Radioisotopes are cleared largely in urine. That means every cycle sends a share of the dose past the kidneys, and it means that how well you drink and how often you pass urine on infusion day genuinely matters. In most patients the effect shows up only as a small change in a blood test rather than as anything you feel.
- Kidney blood tests are done before the course begins and again before each cycle.
- You are asked to drink well and pass urine often on infusion day, so unbound isotope clears quickly.
- Existing kidney disease, a single working kidney, or an obstructed urinary tract means a more careful assessment before treatment is offered.
- Dehydration from vomiting or a stomach upset around a cycle is worth reporting, because it changes how the isotope clears.
The bone marrow
Bone marrow is where blood cells are made, and it lies immediately alongside bone. When the disease being treated sits in bone, the marrow beside it receives radiation as well. Counts usually reach their lowest point a few weeks after a cycle rather than the day after, which is exactly why testing is timed to the schedule and not to how you feel.
- Haemoglobin, white cells and platelets are checked before every cycle.
- A cycle is postponed by a week or two if counts have not recovered — routine practice, not a failure.
- Previous chemotherapy or widespread disease in bone means less marrow reserve to start with, so monitoring is closer.
- Fever, chills, bleeding gums, nosebleeds or unusual bruising are reported the same day, not at the next appointment.
- Counts are still followed for a period after the final cycle, because recovery continues after treatment ends.
Guideline bodies including NCCN and ASTRO treat kidney function and marrow reserve as the standard limits for continuing a radioisotope course. This is why the number of cycles in your plan is reviewed as you go rather than fixed at the start — our page on how many cycles of radioisotope therapy you will need explains how that decision is made.
Question three
What is monitored, and when?
Blood counts and kidney function are the two tests that decide whether the next cycle goes ahead. Symptoms are reviewed at every visit. Imaging is repeated at set points rather than after each cycle. Extra tests are added depending on which radioisotope you are having.
Here is the rhythm of a typical course, so you can see where each test sits.
1
Before the course starts: the baseline
Full blood count, kidney function and, depending on the isotope, liver, thyroid and calcium tests. This baseline is what every later result is compared against, so ask for a copy and keep it. Imaging done for eligibility also becomes part of the baseline.
2
Before every cycle: the go or no-go check
Blood counts and kidney function are repeated and read before the dose is prepared. If a result is below the centre's threshold the cycle is postponed rather than pushed through. A postponed cycle is a normal part of a course, not a sign the treatment has stopped working.
3
Two to four weeks after a cycle: the low point
Some centres add a mid-cycle blood test because counts usually reach their lowest point in this window. If you feel well but the test is booked anyway, that is why. Report fever, bleeding or unusual bruising in this window without waiting for the appointment.
4
At set points: imaging and symptom review
Scans are repeated at planned intervals, not after every cycle, and are read together with your symptoms and your blood results. This is the review where the plan for the remaining cycles is confirmed, adjusted or stopped.
5
After the final cycle: follow-up that continues
Blood counts and kidney function are followed for a period after treatment ends, because marrow recovery and kidney readings continue to change. Keep every report in one folder and carry it to each review — it saves repeating tests and it makes a second opinion far quicker.
Do not wait for the next appointment
Which side effects need a call the same day?
Most side effects can wait for your next review. A small number cannot. Fever, bleeding, sudden severe bone pain, new leg weakness or a clear drop in how much urine you pass are all checked urgently, because each can point to something that is easier to treat early.
- Fever or chills — especially in the weeks after a cycle, when white cells may be at their lowest.
- Bleeding gums, nosebleeds or unusual bruising — possible signs of a low platelet count.
- Sudden severe bone pain, or new weakness or numbness in the legs — assessed the same day, not managed at home.
- Passing much less urine, or difficulty passing urine — the kidneys are how the isotope leaves your body, so this is checked quickly.
- Vomiting that stops you drinking — dehydration around a cycle matters more here than it would otherwise.
Your coordinator is reachable on 1800 202 8726 through your course. If a symptom is severe or you cannot reach anyone, go to the nearest emergency department and take your treatment records with you.
Not one profile, several
How do side effects differ between radioisotope treatments?
Different isotopes go to different places in the body, so the side effects follow the target rather than the diagnosis. This is the table to bring to a second-opinion appointment.
Side effects follow the isotope, not the diagnosis. A treatment that seeks a target on the cancer cell also reaches normal tissue carrying that same target, such as salivary glands. A bone-seeking isotope concentrates near marrow instead. What clears through the kidneys or the gut sets the rest of the profile.
| Treatment | Where the dose concentrates | What patients most often notice |
|---|---|---|
| Lu-177 therapy for advanced prostate cancer | Disease deposits carrying the surface target; salivary glands and kidneys take a share | Dry mouth, tiredness, mild nausea, falling counts — see Lu-177 therapy for advanced prostate cancer |
| Lu-177 therapy for neuroendocrine tumours | Tumour cells carrying the matching receptor; kidneys and marrow take a share | Nausea on infusion day, tiredness, falling counts; dry mouth is less prominent |
| Radium-223 for bone metastases | Areas of active bone turnover, so the dose stays close to bone | Loose stools or nausea, tiredness, falling counts — see Radium-223 for prostate cancer bone metastases |
| Samarium or strontium for widespread bone pain | Painful bone deposits across the skeleton | A short pain flare first, then relief in many patients; falling counts is the main limit — see samarium and strontium injections for bone pain |
| Radioiodine for thyroid cancer | Thyroid tissue; salivary glands and tear glands take a share | Dry mouth, altered taste, dry eyes, neck tenderness — see salivary gland effects after radioiodine |
One thing is shared across all of them: for a short period after each dose you carry measurable radioactivity, so written distance, toilet and laundry rules apply at home. Those are covered in our guide to household precautions after radioisotope therapy.
On cost: side-effect monitoring blood tests are usually billed separately from the cycles themselves, so ask for them to be named in your written estimate. Any figure quoted is indicative, as of August 2026, and varies by centre — our page on the cost of theranostics and radioisotope therapy in India sets out what an itemised estimate should contain.
Side effects are managed, not endured
One conversation can change how the next cycle feels
Most of what troubles patients between cycles has a straightforward answer. You should not have to guess which symptoms matter and which do not.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Lu-177 and radioisotope therapy side effects — your questions answered
What are the common side effects of Lu-177 therapy?
The most commonly reported effects are tiredness, mild nausea and a dry mouth, with a fall in blood counts and, in some patients, a short flare of bone pain in the first days after a cycle. Kidney blood tests can drift over a full course. Effects tend to build gradually across cycles rather than arriving all at once, which is why they are reviewed before every cycle instead of only at the end. Your treating team gives you a written list of what to watch for, what is expected and what needs a phone call the same day.
How does Lu-177 therapy affect the kidneys?
The part of the dose that is not taken up by cancer deposits leaves the body through the kidneys, so the kidneys receive a share of the radiation on the way out. In most patients this shows up only as a small change in routine blood tests rather than as anything you feel. Kidney function is checked before the course starts and again before each cycle. Good fluid intake around each infusion helps the isotope clear faster. Patients with existing kidney disease, a single kidney or an obstructed urinary tract are assessed more carefully before treatment is offered.
Does radioisotope therapy affect bone marrow and blood counts?
Yes, it can. Bone marrow sits next to bone, so marrow near treated bone deposits receives some radiation, and haemoglobin, white cells or platelets can fall over a course. The lowest point usually comes a few weeks after a cycle rather than immediately. Counts are checked before every cycle and the cycle is postponed if they have not recovered enough, which is routine rather than a setback. People who have already had chemotherapy or who have widespread bone disease are watched more closely, because their marrow reserve is smaller to begin with.
What is monitored between cycles of radioisotope therapy?
Blood counts and kidney function are the two that decide whether the next cycle goes ahead. Liver tests, thyroid tests and calcium may be added depending on which radioisotope you are having. Your symptoms are reviewed at every visit, and imaging is repeated at set points rather than after every cycle. Nothing about the monitoring is optional: a cycle is only confirmed once the current results are seen, so ask for your numbers and keep a copy of every report in one folder.
Are the side effects of radioisotope therapy different from external beam radiation?
Yes, and this is the part most people get wrong. External beam radiation is aimed at one area from outside, so its side effects are mostly local, such as skin changes or soreness in the treated region. Radioisotope therapy travels in the bloodstream, so there is no skin reaction and no daily hospital trip, but organs that handle or take up the isotope get a share of the dose. That is why kidneys, bone marrow and salivary glands appear on this list and would not appear on a generic radiation side effect page.
Which side effects after radioisotope therapy need an urgent call?
Call your treating team the same day for fever or chills, bleeding gums, nosebleeds or unusual bruising, sudden severe bone pain, new weakness or numbness in the legs, difficulty passing urine or a clear drop in how much urine you are passing, and persistent vomiting that stops you drinking. These are checked urgently because they can point to a low blood count, a kidney problem or a bone deposit pressing on a nerve. You can reach a coordinator on 1800 202 8726 at any time during your course.
This page is a general explainer about the side effects of Lu-177 and other radioisotope treatments, not medical advice and not a recommendation for your case. Only your treating oncology and nuclear medicine team, working from your own scans and blood tests, can say what applies to you.